Literature DB >> 17676080

Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics.

S McDougall1, D G Arthur, M A Bryan, J J Vermunt, A M Weir.   

Abstract

AIM: To compare the proportions of clinical and bacteriological cure of glands of dairy cows diagnosed with clinical mastitis, following treatment with one of three different intramammary antibiotic preparations.
METHODS: Cows from dairy cow herds (n=28) across New Zealand which were diagnosed with clinical mastitis in one or more glands at any stage of lactation were randomly assigned at the cow level within sequentially presented groups of three animals to be treated with one of three intramammary antibiotics. The treatments were 1 g procaine penicillin, 0.25 g cefuroxime, and a combination of 1 g procaine penicillin and 0.5 g dihydrostreptomycin (DHS). All treatments were infused on three occasions at 12-hourly intervals. Duplicate milk samples were collected for bacteriology before initial treatment, and 21-42 days later. Logistic regression or generalised linear mixed models were used to analyse the proportion of cows or quarters retreated for mastitis within 30 days of initial treatment ('clinical treatment failure'), and the proportion of glands from which bacteria were isolated initially but from which the same bacterial species was not re-isolated ('bacteriological cure').
RESULTS: The annual herd average cumulative incidence rate of clinical mastitis was 12.7 cases/100 cows. The incidence rate was higher in young (2-year-old) and old (> or = 9-year-old) cows relative to 3- and 4-year-old cows, and was higher in Friesian than Jersey or crossbred cows. Streptococcus uberis was the pathogen most commonly isolated, and its relative prevalence declined with time postpartum. Cows treated with cefuroxime were more likely (p<0.01) to be re-treated for clinical mastitis in the 30 days after initial treatment than cows treated with procaine penicillin or procaine penicillin and DHS. Bacteriological cure occurred in 74% of treated glands and there was no difference in the proportion of cures among the treatments (p=0.4). The proportion of cures was lower when treatment occurred 28-72 days after calving (p<0.01) and if a major pathogen was isolated (p<0.001). CONCLUSIONS AND CLINICAL RELEVANCE: There was no benefit in terms of clinical or bacteriological cure rate in treating clinical mastitis cases with the combination of procaine penicillin and DHS compared to treatment with procaine penicillin alone. The proportion of clinical mastitis cases re-treated differed among herds, and more cows treated with cefuroxime were retreated within 30 days of initial treatment. However, the bacteriological cure proportion was the same among the treatments. Cure proportions were lower in cows from which major mastitis pathogens were isolated and when treatment commenced 28-72 days after calving.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676080     DOI: 10.1080/00480169.2007.36762

Source DB:  PubMed          Journal:  N Z Vet J        ISSN: 0048-0169            Impact factor:   1.628


  10 in total

1.  Relationship between season, lactation number and incidence of clinical mastitis in different stages of lactation in a Holstein dairy farm.

Authors:  Maede Moosavi; Abdolah Mirzaei; Mohsen Ghavami; Amin Tamadon
Journal:  Vet Res Forum       Date:  2014       Impact factor: 1.054

2.  Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle.

Authors:  Wen Wang; Yunmei Song; Kiro Petrovski; Patricia Eats; Darren J Trott; Hui San Wong; Stephen W Page; Jeanette Perry; Sanjay Garg
Journal:  Drug Des Devel Ther       Date:  2015-01-22       Impact factor: 4.162

3.  Evaluation of an On-Farm Culture System (Accumast) for Fast Identification of Milk Pathogens Associated with Clinical Mastitis in Dairy Cows.

Authors:  Erika Korzune Ganda; Rafael Sisconeto Bisinotto; Dean Harrison Decter; Rodrigo Carvalho Bicalho
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

4.  Efficacy of cefquinome and a combination of cloxacillin and ampicillin for treatment of dairy cows with Streptococcus agalactiae subclinical mastitis.

Authors:  Rodolfo Santos Rossi; Ariadne Ferreira Amarante; Simony Trevisan Guerra; Giulia Soares Latosinski; Bruna Fernanda Rossi; Vera Lucia Mores Rall; Jose Carlos de Figueiredo Pantoja
Journal:  PLoS One       Date:  2019-04-25       Impact factor: 3.240

Review 5.  What Is Success? A Narrative Review of Research Evaluating Outcomes of Antibiotics Used for Treatment of Clinical Mastitis.

Authors:  Pamela L Ruegg
Journal:  Front Vet Sci       Date:  2021-02-02

6.  Therapy of Subclinical Mastitis during Lactation.

Authors:  Scott McDougall; Laura M Clausen; Hassan M Hussein; Chris W R Compton
Journal:  Antibiotics (Basel)       Date:  2022-02-07

7.  Intramammary treatment using allogeneic pure platelet-rich plasma in cows with subclinical mastitis caused by Gram-positive bacteria.

Authors:  Paulo C Duque-Madrid; Juan Velasco-Bolaños; Alejandro Ceballos-Márquez; Catalina López; Jorge U Carmona
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

8.  Protective effect of anti-SUAM antibodies on Streptococcus uberis mastitis.

Authors:  Raúl A Almeida; Oudessa Kerro-Dego; María E Prado; Susan I Headrick; Mark J Lewis; Lydia J Siebert; Gina M Pighetti; Stephen P Oliver
Journal:  Vet Res       Date:  2015-11-19       Impact factor: 3.683

9.  Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows.

Authors:  P M Down; A J Bradley; J E Breen; M J Green
Journal:  Prev Vet Med       Date:  2017-07-10       Impact factor: 2.670

Review 10.  Keeping Dairy Cows for Longer: A Critical Literature Review on Dairy Cow Longevity in High Milk-Producing Countries.

Authors:  Gabriel M Dallago; Kevin M Wade; Roger I Cue; J T McClure; René Lacroix; Doris Pellerin; Elsa Vasseur
Journal:  Animals (Basel)       Date:  2021-03-13       Impact factor: 2.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.